JP2015516264A5 - - Google Patents

Download PDF

Info

Publication number
JP2015516264A5
JP2015516264A5 JP2015512646A JP2015512646A JP2015516264A5 JP 2015516264 A5 JP2015516264 A5 JP 2015516264A5 JP 2015512646 A JP2015512646 A JP 2015512646A JP 2015512646 A JP2015512646 A JP 2015512646A JP 2015516264 A5 JP2015516264 A5 JP 2015516264A5
Authority
JP
Japan
Prior art keywords
antigen
antibody
binding fragment
particles
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015512646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015516264A (ja
JP6404211B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/031744 external-priority patent/WO2013172966A1/en
Publication of JP2015516264A publication Critical patent/JP2015516264A/ja
Publication of JP2015516264A5 publication Critical patent/JP2015516264A5/ja
Application granted granted Critical
Publication of JP6404211B2 publication Critical patent/JP6404211B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015512646A 2012-05-14 2013-03-14 体外血液改質のためのシステムおよび方法 Active JP6404211B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261646674P 2012-05-14 2012-05-14
US61/646,674 2012-05-14
PCT/US2013/031744 WO2013172966A1 (en) 2012-05-14 2013-03-14 Systems and methods for extracorporeal blood modification

Publications (3)

Publication Number Publication Date
JP2015516264A JP2015516264A (ja) 2015-06-11
JP2015516264A5 true JP2015516264A5 (https=) 2016-05-12
JP6404211B2 JP6404211B2 (ja) 2018-10-10

Family

ID=49584139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015512646A Active JP6404211B2 (ja) 2012-05-14 2013-03-14 体外血液改質のためのシステムおよび方法

Country Status (5)

Country Link
US (3) US20150132312A1 (https=)
EP (1) EP2849817B1 (https=)
JP (1) JP6404211B2 (https=)
ES (1) ES2725573T3 (https=)
WO (1) WO2013172966A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150071935A1 (en) * 2012-05-27 2015-03-12 Marv Enterprises, LLC Treatment for the rapid amelioration of clinical depression
KR102271653B1 (ko) * 2013-06-07 2021-07-05 백스터 인터내셔널 인코포레이티드 트리하이드록시페닐기를 포함하는 화합물을 사용한 기판 상에의 활성제의 고정화
KR20160102440A (ko) * 2013-12-27 2016-08-30 엘리아스 세라퓨틱스 인코포레이티드 혈장 분리 반출 장치
DE102015207228A1 (de) * 2015-04-21 2016-10-27 Vetter Pharma-Fertigung GmbH & Co. KG Primärpackmittel und Verfahren zur Herstellung eines Primärpackmittels
US10064653B2 (en) 2015-06-08 2018-09-04 The Board Of Trustees Of The Leland Stanford Junior University Intravascular magnetic wire for detection, retrieval or elimination of disease-associated biomarkers and toxins
EP3735281B1 (en) 2018-01-05 2024-11-27 Path Ex, Inc. Device for the capture and removal of disease material from fluids
CA3154382A1 (en) 2019-09-13 2021-03-18 The Trustees Of Indiana University Devices and methods for modulating adma in blood
US12521475B2 (en) * 2020-04-08 2026-01-13 Arizona Board Of Regents On Behalf Of Arizona State University Method, device, and product for treating a body fluid of a patient with an inflammatory cytokine storm by binding an antibody to a cytokine antigen in the body fluid to form an antigen-antibody complex that is removed from the body fluid to reduce the amount of the cytokines in the body fluid
CN112090410B (zh) * 2020-07-29 2023-11-10 健帆生物科技集团股份有限公司 具有互穿网络包膜的血液净化吸附剂、制备方法及灌流器
WO2024030085A1 (en) * 2022-08-05 2024-02-08 Innowayrg Arastirma Gelistirme Ve Danismanlik Hizmetleri Sanayi Ve Ticaret Anonim Sirketi A device for cleaning heavy metal-bound mediators in body fluids and organs
WO2024076704A1 (en) * 2022-10-05 2024-04-11 Immunicom, Inc. Il-6 removal
KR102694305B1 (ko) * 2023-05-23 2024-08-13 주식회사 월드바이오텍 치열교정 브라켓

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3523615A1 (de) * 1985-07-02 1987-01-15 Cytomed Medizintechnik Medizinisches geraet, insbesondere kanuele, katheter oder implantat
US5589563A (en) * 1992-04-24 1996-12-31 The Polymer Technology Group Surface-modifying endgroups for biomedical polymers
AU4860600A (en) * 1999-06-03 2000-12-28 Advanced Extravascular Systems One step removal of unwanted molecules from circulating blood
US6969367B2 (en) * 2000-02-02 2005-11-29 Xepmed, Inc. Extracorporeal pathogen reduction system
US20030120202A1 (en) * 2001-12-21 2003-06-26 Gordon Lucas S. Magnetic extracorporeal circuit for removal of medical agents
US20040028687A1 (en) * 2002-01-15 2004-02-12 Waelti Ernst Rudolf Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues
US8211310B2 (en) * 2006-11-20 2012-07-03 Cytosorbents, Inc. Size-selective polymer system
US20090191175A1 (en) * 2006-11-21 2009-07-30 University Of Southern California Therapeutic methods using peg-conjugated agents and devices for performing the same
WO2009079664A1 (en) * 2007-12-19 2009-06-25 Georgia Tech Research Corporation Modification of biomaterials with microgel films
CA2728270A1 (en) * 2008-06-17 2009-12-23 Georgia Tech Research Corporation Superparamagnetic nanoparticles for removal of cells, pathogens or viruses
US8430831B2 (en) * 2009-02-25 2013-04-30 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
CA2776613A1 (en) * 2009-10-07 2011-04-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Educatio N Devices, systems and methods for cell modification
WO2011112873A2 (en) * 2010-03-10 2011-09-15 Paul Tebbey Extracorporeal immunoadsorption treatment

Similar Documents

Publication Publication Date Title
JP2015516264A5 (https=)
Sun et al. High-purity capture of CTCs based on micro-beads enhanced isolation by size of epithelial tumor cells (ISET) method
US11648560B2 (en) Particle separation systems and methods
JP6453592B2 (ja) 血液検体の処理方法
Islam et al. Microfluidic sorting of cells by viability based on differences in cell stiffness
Hyun et al. Negative enrichment of circulating tumor cells using a geometrically activated surface interaction chip
Ding et al. Aptamer-based nanostructured interfaces for the detection and release of circulating tumor cells
JP6364946B2 (ja) 分離構造体及び分離方法
Yin et al. Detection of circulating tumor cells by fluorescence microspheres-mediated amplification
Yang et al. A chemical method for specific capture of circulating tumor cells using label-free polyphenol-functionalized films
JP2022176962A (ja) 疾患材料の検出、捕捉、または除去のための流体デバイス
JP7154276B2 (ja) 標的粒子または細胞の選択的濃縮のためのフローセル
JP2016136152A5 (ja) 下着に取り付けられたサンプリング装置を介して生体由来の化学物質を分析する方法および下着
CN102911864B (zh) 一种血液中稀有细胞的分离仪
Yoo et al. Highly dense, optically inactive silica microbeads for the isolation and identification of circulating tumor cells
CN103889556A (zh) 在引入亲和性和大小两者的微流体芯片上的循环肿瘤细胞捕获
Huang et al. Efficient purification and release of circulating tumor cells by synergistic effect of biomarker and SiO2@ gel-microbead-based size difference amplification
RU2013148071A (ru) Аналогичное диализу терапевтическое (dlt) устройство
WO2009131722A3 (en) Methods and devices for immobilization of single particles
Bohmer et al. Removal of cells from body fluids by magnetic separation in batch and continuous mode: influence of bead size, concentration, and contact time
JP2014506118A5 (https=)
JP2008122372A5 (https=)
JP2019528810A5 (https=)
WO2016075410A1 (fr) Procédé et dispositif de tri sélectif, spécifique et simultané de cellules rares cibles dans un échantillon biologique
Li et al. Multiparameter cell affinity chromatography: separation and analysis in a single microfluidic channel